KemPharm Inc at the RBC Capital Markets 2017 Global Healthcare
Feb 22, 2017 from 9:00 AM to 9:00 AM EST
Location
The New York Palace Hotel
KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.